Kei Kishimoto

Company: Selecta Biosciences

Job title: CSO

Seminars:

Synergizing Activity of ImmTOR Tolerogenic Nanoparticles & an IL-2 Mutein to Expand Antigen- Specific Tregs 2:00 pm

Co-administering antigens with ImmTOR nanoparticles encapsulating rapamycin to induce antigen-specific tolerance Using ImmTOR combination with a fungal-derived uricase enzyme in Ph3 clinical trials in for the treatment of chronic refractory gout Combining ImmTOR with an IL-2 mutein and antigen to induce massive expansion of antigen-specific Tregs in vivoRead more

day: Day one Track 2 AM